Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present GB Sciences, Inc. (OTC: GBLX).

Full DD Report for GBLX

You must become a subscriber to view this report.


Recent News from (OTC: GBLX)

NYC sees marijuana revenue stream
New York state would gain $435.7M annually in tax revenue for legalized weed, while New York City would get about $336M, according to NYC Comptroller Scott Stringer. More news on: Aurora Cannabis Inc., Aero Grow International, Inc., American Cannabis Company, Inc., Read more ......
Source: SeekingAlpha
Date: May, 17 2018 04:56
GB Sciences' Acquisition Of NevadaPURE Is Terminated
LAS VEGAS , May 9, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), the previously announced proposed acquisition of NevadaPURE, LLC, a Nevada limited liability company, by GB Sciences has been terminated. In accordance with the terms of the non-binding letter of intent signed...
Source: PR Newswire
Date: May, 09 2018 08:19
Marijuana Stocks for Investors in the Free Cannabis Investor Magazine
MIAMI, FL / ACCESSWIRE / May 7, 2018 / Cannabis Investor Magazine , the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its May 2018 issue of the Canadian CannaInvestor Magazine and th...
Source: ACCESSWIRE
Date: May, 07 2018 10:00
Subsidiary Industries Prepare for Growing Cannabis Market
CannabisNewsWire Editorial Coverage : Impending legislation in Canada is the most recent step in the spread of legal cannabis consumption. As the industry grows, so do the support businesses supplying related services for retailers and consumers. Global Payout, Inc. (GOHE) ( GOHE profile ...
Source: CannabisNewsWire
Date: May, 02 2018 09:00
GB Sciences is Exploring a Cannabis Therapy for Parkinson's, Analysts Review
NEW YORK, NY / ACCESSWIRE / May 2, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company...
Source: ACCESSWIRE IA
Date: May, 02 2018 08:05
NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) - Metrospaces, Inc. (MSPC) announces another record revenue month in March 2018 for Etelix.
Mr. Silva stated: “Our fundamentals continue to be very strong, our growth continues strong and Etelix management continues to hit record revenue numbers.  Management’s budget revenue for April 2018 was $778,906; however, the company did 7% higher revenue than our forecast, ...
Source: Stock Market Press
Date: April, 25 2018 09:22
Cannabis Industry Keeps Making Steps Forward
CannabisNewsWire Editorial Coverage : As legalization spreads, the cannabis industry is achieving a new level of maturity, with a wide range of products and support services. Global Payout, Inc. (OTC: GOHE) ( GOHE Profile ) is providing payment and consulting services for cannabis compa...
Source: CannabisNewsWire
Date: April, 25 2018 09:00
GVC Capital and Trickle Research Announce Presenter Schedule for Rocky Mountain MicroCap Conference II in Denver on April 24, 2018
DENVER, CO / ACCESSWIRE / April 20, 2018 / GVC Capital LLC ("GVC") and Dave Lavigne at Trickle Research LLC ("Trickle Research") will host the Rocky Mountain MicroCap Conference II on April 24, 2018, in Denver at Coors Field. The Rocky Mountain MicroCap Conference II is a single track invest...
Source: ACCESSWIRE
Date: April, 20 2018 13:00
GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire's "Stock Day" Podcast
PHOENIX, April 19, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB:GBLX) (“the “Company”), today announced CEO, John Poss, returned to Uptick Newswire’s “Stock Day” podcast with Everett Jolly for an operational update. “GB Sciences ...
Source: GlobeNewswire
Date: April, 19 2018 09:00
Budding Legal Cannabis Industry Offers Opportunity Amid Challenge, Chaos
CannabisNewsWire Editorial Coverage : Albert Einstein may have said it best: “In the middle of difficulty, lies opportunity.” The changing landscape of the cannabis industry perfectly illustrates this quote, and who better to know it than the companies and individuals involved i...
Source: CannabisNewsWire
Date: April, 18 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-160.260.258550.270.25494,338
2018-08-150.278950.257450.2790.2451,054,036
2018-08-140.2650.2580.2650.251352,133
2018-08-130.285050.260.28790.2502951,700
2018-08-100.266250.252950.2750.24351,717,113

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-15426,5191,087,73639.2116Short
2018-08-14145,563344,13342.2985Short
2018-08-13480,995944,20050.9421Short
2018-08-10523,7751,717,11330.5032Cover
2018-08-09528,1291,602,13632.9641Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GBLX.


About GB Sciences, Inc. (OTC: GBLX)

Logo for GB Sciences, Inc. (OTC: GBLX)

The Company seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical grade cannabis, cannabis concentrates and cannabinoid therapies. Although we believe that maximum shareholder value will ultimately be achieved through the development, production and marketing of certified cannabinoid medicines, therapies and treatments, in order to generate cash flow and near term profitability, we intend to cultivate and dispense cannabis for medical purposes in both Nevada and other states which permit such sales and in which we and our operating partners are able to obtain cultivation and dispensing licenses. We seek to become a trusted producer of consistent and efficacious medicinal strains and products, combining both cannabinoids and terpenes, which we intend to market in those states within the United States and in other countries where the sale of medical cannabis products are permitted. In addition, subject to obtaining Food and Drug Administrative FDA certification, we intend to market our cannabinoid based drug discoveries on a world wide basis.

 

Contact Information

 

 

Current Management

  • John Poss / President, CEO
    • Mr. Poss has over years of experience working as a consultant to companies facing major transitions and transformations. Mr. Poss began his career in the Washington, D.C. office of Arthur Andersen amp Co. and has served as Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Technology Officer of both public and private companies in such diverse industries as homebuilding, mining, telecommunications, manufacturing, logistics, construction lending and mortgage banking. For the past three years Mr. Poss served as Chief Executive Officer of Experiential Teaching Online Corp., an educational content developer and for four years prior thereto owned and operating his own consulting firm. Mr. Poss has also has worked extensively internationally, successfully negotiating agreements in countries throughout Asia, Europe and the Americas. Mr. Poss graduated from the University of Texas in with a degree in accounting.
  • Ksenia Griswold / CFO, Vice President
  • Leslie Bocskor /
    • Mr. Bocskor, age , combines two years of experience in the cannabis industry and a total of years in senior management in the financial industry. Since June , Mr. Bocskor has served as the President of Venture Catalyst LLC, a consulting company. From February through September , Mr. Bocskor was employed in the investment banking division of Network One Financial, Inc. From May through June , Mr. Bocskor was Managing Partner of Lenox Hill Partners, LLC an advisory firm that focused on corporate finance and business consulting. Currently, Mr. Bocskor serves as the Chairman of the Board of The Nevada Cannabis Industry Association, a trade association working to establish an exemplary legal Cannabis Industry in the State of Nevada. Mr. Bocskor is also Chairman of the Board for the Figment Project, an arts and cultural organization. The board of directors believes that Mr. Bocskor s experience in the legal cannabis industry and extensive experience in the financial markets will be critical in supporting the Company s growth plans.
  • John Poss /
    • Mr. Poss has over years of experience working as a consultant to companies facing major transitions and transformations. Mr. Poss began his career in the Washington, D.C. office of Arthur Andersen amp Co. and has served as Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Technology Officer of both public and private companies in such diverse industries as homebuilding, mining, telecommunications, manufacturing, logistics, construction lending and mortgage banking. For the past three years Mr. Poss served as Chief Executive Officer of Experiential Teaching Online Corp., an educational content developer and for four years prior thereto owned and operating his own consulting firm. Mr. Poss has also has worked extensively internationally, successfully negotiating agreements in countries throughout Asia, Europe and the Americas. Mr. Poss graduated from the University of Texas in with a degree in accounting.
  • Andrea SmallHoward /
  • Shane Terry /
    • Mr. Terry is an independent consultant provides advisory services to Medical Marijuana Establishments MME s in Nevada and other states. He served as a CEO of NuVeda NMS, LLC, a company that operates marijuana dispensaries in Nevada, from until . He is also a former President of the Nevada Dispensary Association From until Mr. Terry served as F Weapons Officer and Instructor Pilot. Mr. Terry is a decorated veteran of the United States Air Force, whose career as an Officer and F fighter pilot included earning two Air Medals for combat action over Iraq and Afghanistan while leading his team to three Air Force Outstanding Unit awards. The Company is currently discussing compensation arrangement with Mr. Terry pursuant to which he will serve as the Company s Board Member.

Current Share Structure

  • Market Cap: $91,609,801 - 03/09/2018
  • Authorized: 200,000,000 - 02/05/2018
  • Issue and Outstanding: 155,931,576 - 02/14/2018
  • Float: 6,631,667 - 01/22/2015

 


Recent Filings from (OTC: GBLX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: January, 12 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: December, 22 2017
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: December, 22 2017
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: November, 28 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Quarterly Report - GB Sciences, Inc 10-Q September 30, 2017
Filing Type: Quarterly Report - GB Sciences, Inc 10-Q September 30, 2017Filing Source: OTC Markets
Filing Date: November, 20 2017

 

 


Daily Technical Chart for (OTC: GBLX)

Daily Technical Chart for (OTC: GBLX)


Stay tuned for daily updates and more on (OTC: GBLX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GBLX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GBLX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of GBLX and does not buy, sell, or trade any shares of GBLX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/